Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinchen Siwei Decoction (YCSWD) is a Traditional Chinese Medicine (TCM) herbal formula specifically designed for the treatment of neonatal jaundice and cholestasis. It is a four-herb variation of the classic Yinchenhao Decoction, typically comprising *Artemisia capillaris* (Yinchen), *Gardenia jasminoides* (Zhizi), *Rheum palmatum* (Dahuang), and *Phellodendron amurense* (Huangbai). The formula works synergistically to clear damp-heat, promote choleresis (bile flow), and facilitate the excretion of bilirubin. Pharmacologically, its active constituents—such as capillarisin and geniposide—act as agonists for nuclear receptors like the Farnesoid X receptor (FXR) and Pregnane X receptor (PXR), which regulate bile acid synthesis and transport. It is currently being studied in clinical trials as an adjunct to ursodeoxycholic acid (UDCA) for managing neonatal cholestasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinchen Siwei Decoction.